BDBM636326 US20230365546, Compound 109

SMILES C[C@H](NC(=O)c1cn(C)c2ccc(cc12)-c1ccc2nc(NC(=O)C3CC3)cn2n1)c1cccc(F)c1

InChI Key InChIKey=SKGVUWMOEGCZJR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 636326   

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Origiant Pharmaceutical

US Patent
LigandPNGBDBM636326(US20230365546, Compound 109)
Affinity DataIC50: 5.5nMAssay Description:In vitro kinase assays were conducted using Kinase Profiler services provided by Eurofins. The experimental method was as follows: the small molecule...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Origiant Pharmaceutical

US Patent
LigandPNGBDBM636326(US20230365546, Compound 109)
Affinity DataIC50: 21nMAssay Description:Inhibition of human RIPK1 (1 to 294 residues) preincubated for 15 mins followed by [gamma-33P]ATP addition and measured after 40 mins by scintillatio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed